Patients' views about taking a polypill to manage cardiovascular risk: a qualitative study in primary care
A 'polypill' containing a combination of antihypertensives and statins could prevent up to 80% of cardiovascular disease (CVD) events. To investigate patients' opinions about the use of a polypill for CVD prevention. Qualitative study of 17 patients from seven primary care practices in Birmingham, UK. Patients were recruited through purposive sampling to maximise variation of characteristics. Semi-structured interviews were conducted with responders. Results were analysed and reported using a qualitative description approach. Patients expressed concerns that polypill prescription for primary prevention simply on the basis of age was unnecessary and would lead to side effects, despite recognising potential benefits. For high-risk patients, or for secondary prevention, a polypill was deemed more acceptable, but was still felt to require regular monitoring of blood pressure and cholesterol. Patients were sceptical about the role of a polypill as a 'blanket' approach. If a population strategy offering a polypill to all people over a certain age was to be implemented, it would need to be supported by patient education..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
---|---|
Enthalten in: |
British journal of general practice - 65(2015), 636, Seite e447 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Virdee, Satnam K [VerfasserIn] |
---|
Links: |
---|
RVK: |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1968825398 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1968825398 | ||
003 | DE-627 | ||
005 | 20230714173116.0 | ||
007 | tu | ||
008 | 160206s2015 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a PQ20160617 |
035 | |a (DE-627)OLC1968825398 | ||
035 | |a (DE-599)GBVOLC1968825398 | ||
035 | |a (PRQ)p834-3cd7ff00e817e0bdf392d4cfed6ab89b58d92345f8698f453b6acdddaa57bddd0 | ||
035 | |a (KEY)0109614120150000065063600447patientsviewsabouttakingapolypilltomanagecardiovas | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q DNB |
084 | |a XA 34050 |q AVZ |2 rvk | ||
100 | 1 | |a Virdee, Satnam K |e verfasserin |4 aut | |
245 | 1 | 0 | |a Patients' views about taking a polypill to manage cardiovascular risk: a qualitative study in primary care |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a A 'polypill' containing a combination of antihypertensives and statins could prevent up to 80% of cardiovascular disease (CVD) events. To investigate patients' opinions about the use of a polypill for CVD prevention. Qualitative study of 17 patients from seven primary care practices in Birmingham, UK. Patients were recruited through purposive sampling to maximise variation of characteristics. Semi-structured interviews were conducted with responders. Results were analysed and reported using a qualitative description approach. Patients expressed concerns that polypill prescription for primary prevention simply on the basis of age was unnecessary and would lead to side effects, despite recognising potential benefits. For high-risk patients, or for secondary prevention, a polypill was deemed more acceptable, but was still felt to require regular monitoring of blood pressure and cholesterol. Patients were sceptical about the role of a polypill as a 'blanket' approach. If a population strategy offering a polypill to all people over a certain age was to be implemented, it would need to be supported by patient education. | ||
540 | |a Nutzungsrecht: © British Journal of General Practice 2015. | ||
700 | 1 | |a Greenfield, Sheila M |4 oth | |
700 | 1 | |a Fletcher, Kate |4 oth | |
700 | 1 | |a McManus, Richard J |4 oth | |
700 | 1 | |a Mant, Jonathan |4 oth | |
773 | 0 | 8 | |i Enthalten in |t British journal of general practice |d London : Royal College of General Practitioners, 1990 |g 65(2015), 636, Seite e447 |w (DE-627)130897965 |w (DE-600)1043148-2 |w (DE-576)10096091X |x 0960-1643 |7 nnns |
773 | 1 | 8 | |g volume:65 |g year:2015 |g number:636 |g pages:e447 |
856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26077268 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4219 | ||
912 | |a GBV_ILN_4305 | ||
936 | r | v | |a XA 34050 |
951 | |a AR | ||
952 | |d 65 |j 2015 |e 636 |h e447 |